Lumos Pharma, Inc. - stock earnings
LUMO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | - / -1.1995000000 | - | - / 308652 | - |
LUMO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -9.5 million USD | 826000 USD |
| 2023Q3 | -8.3 million USD | 7000 USD |
| 2023Q2 | -8.9 million USD | 527000 USD |
| 2023Q1 | -6.7 million USD | 691000 USD |
| 2022Q4 | -7.7 million USD | 512000 USD |
| 2022Q3 | -7.0 million USD | 497000 USD |
| 2022Q2 | -7.8 million USD | 403000 USD |
| 2022Q1 | -7.7 million USD | 111000 USD |
| 2021Q4 | -5.6 million USD | 220000 USD |
| 2021Q3 | -7.5 million USD | 3385 USD |
| 2021Q2 | -8.7 million USD | 10000 USD |
| 2021Q1 | -8.6 million USD | 40000 USD |
| 2020Q4 | -2.4 million USD | 40000 USD |
| 2020Q3 | 1.8 million USD | 74000 USD |
| 2020Q2 | -5.4 million USD | 33000 USD |
| 2020Q1 | 340000 USD | 21000 USD |
| 2019Q4 | -8.3 million USD | 433000 USD |
| 2019Q3 | -14.5 million USD | 246000 USD |
| 2019Q2 | -10.1 million USD | 151000 USD |
| 2019Q1 | -10.0 million USD | 106000 USD |
| 2018Q4 | -10.6 million USD | 202000 USD |
| 2018Q3 | -7.4 million USD | 120000 USD |
| 2018Q2 | -17.3 million USD | 2.3 million USD |
| 2018Q1 | -18.3 million USD | 9.9 million USD |
| 2017Q4 | -13.7 million USD | 56000 USD |
| 2017Q3 | -20.6 million USD | 103000 USD |
| 2017Q2 | -16.7 million USD | 10.4 million USD |
| 2017Q1 | -20.9 million USD | 2.8 million USD |
| 2016Q4 | -13.5 million USD | 518000 USD |
| 2016Q3 | -15.5 million USD | 888000 USD |
| 2016Q2 | -32.4 million USD | 2.0 million USD |
| 2016Q1 | -23.7 million USD | 5.7 million USD |
| 2015Q4 | -21.6 million USD | 1.6 million USD |
| 2015Q3 | -15.9 million USD | 844000 USD |
| 2015Q2 | -14.1 million USD | 7.4 million USD |
| 2015Q1 | 11.2 million USD | 39.2 million USD |
| 2014Q4 | 126.9 million USD | 166.0 million USD |
| 2014Q3 | -5.6 million USD | 2.8 million USD |
| 2014Q2 | -9.2 million USD | 212000 USD |
| 2014Q1 | -9.2 million USD | 334000 USD |
| 2013Q4 | -8.0 million USD | 294000 USD |
| 2013Q3 | -8.1 million USD | 265000 USD |
| 2013Q2 | -7.1 million USD | 232000 USD |
| 2013Q1 | -7.9 million USD | 302000 USD |
| 2012Q4 | -6.3 million USD | 299000 USD |
| 2012Q3 | -5.9 million USD | 327000 USD |
| 2012Q2 | -6.3 million USD | 590000 USD |
| 2012Q1 | -4.8 million USD | 471000 USD |
| 2011Q4 | -5.8 million USD | 301000 USD |
| 2011Q3 | -4.0 million USD | 430000 USD |
| 2011Q2 | -4.4 million USD | 537000 USD |
| 2011Q1 | -3.9 million USD | 604000 USD |
| 2010Q4 | -5.0 million USD | 974000 USD |
| 2010Q3 | -5.0 million USD | 375000 USD |
| 2009Q4 | -2.1 million USD | 666000 USD |
LUMO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -34.0 million USD | 2.1 million USD |
| 2022 | -31.1 million USD | 1.5 million USD |
| 2021 | -30.4 million USD | 230000 USD |
| 2020 | -5.7 million USD | 168000 USD |
| 2019 | -43.0 million USD | 936000 USD |
| 2018 | -53.6 million USD | 1.2 million USD |
| 2017 | -72.0 million USD | 390000 USD |
| 2016 | -85.2 million USD | 3.5 million USD |
| 2015 | -40.4 million USD | 36.1 million USD |
| 2014 | 102.9 million USD | 166.0 million USD |
| 2013 | -31.2 million USD | 1.1 million USD |
| 2012 | -23.3 million USD | 1.7 million USD |
| 2011 | -18.1 million USD | 1.9 million USD |
| 2010 | -16.2 million USD | 2.1 million USD |
| 2009 | -9.4 million USD | 934000 USD |
| 2008 | -9.2 million USD | 633000 USD |
LUMO
Price: $2.81
52 week price:
Earnings Per Share: -4.18 USD
P/E Ratio: -0.76
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 22134
Market Capitalization: 21.4 million